Premium
The family office of the founders of Bharat Biotech International Ltd, the maker of Covid-19 vaccine Covaxin, has invested in two companies even as it plans to raise a new investment fund and expand its scope. Bengaluru-based Skegen Management Advisors said Monday it has committed a total of Rs 360 crore ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
